bw 306u has been researched along with Central Nervous System Diseases in 1 studies
hydroxybupropion: active metabolite of bupropion; structure in first source
Central Nervous System Diseases: Diseases of any component of the brain (including the cerebral hemispheres, diencephalon, brain stem, and cerebellum) or the spinal cord.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Carroll, FI | 1 |
| Blough, BE | 1 |
| Mascarella, SW | 1 |
| Navarro, HA | 1 |
| Lukas, RJ | 1 |
| Damaj, MI | 1 |
1 review available for bw 306u and Central Nervous System Diseases
| Article | Year |
|---|---|
Bupropion and bupropion analogs as treatments for CNS disorders.
Topics: Animals; Bupropion; Central Nervous System Diseases; Humans; Protein Binding; Treatment Outcome | 2014 |